Sponsor or institution
Clinical trials and research at Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo that are recruiting, in Colombia. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment | — | Bogotá, Bogota D.C. | Recruiting | Sep 11, 2026 |
| Methylscape test in body fluids for multi-cancer detection in Colombia | — | Bogotá, Bogota D.C. | Recruiting | Aug 3, 2026 |
| Oral, Fecal and Tumor Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy | — | Bogotá, Bogota D.C. | Recruiting | Jun 30, 2026 |
| Vortioxetine for cognitive problems in ALK/ROS1-positive NSCLC treated with lorlatinib | — | Bogotá | Recruiting | Jun 8, 2026 |
All recruiting trials (4)
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
Oral, Fecal and Tumor Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy
This study tests how the oral, gut, and tumor microbiomes relate to response to first-line immunotherapy in Colombian adults with advanced solid cancers.
-
Vortioxetine for cognitive problems in ALK/ROS1-positive NSCLC treated with lorlatinib
This observational study tests whether vortioxetine can help with cognitive and neurological side effects in adults with ALK/ROS1-positive NSCLC who are taking lorlatinib.
Quick answers
How many clinical trials run by Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Colombia. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.